Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2776 results

Clinical Trials / Dec 15, 2025

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Clinical Trials / Dec 16, 2025

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Clinical Trials / Dec 11, 2025

Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Press release / Dec 09, 2025

Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses

Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,2 62% of patients treated with…
Press release / Dec 09, 2025

1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years

Progression-free response stayed consistent across age, BMI, and menopausal status in MONALEESA pooled analysis1 KISQALI is only CDK4/6i to demonstrate statistically significant overall survival (OS…
Clinical Trials / Dec 05, 2025

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Clinical Trials / Dec 05, 2025

Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
Clinical Trials / Dec 04, 2025

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Clinical Trials / Dec 08, 2025

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Clinical Trials / Dec 03, 2025

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors